Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
The Prostate|August 2, 2022
Association between duration of gonadotrophin-releasing hormone agonist use and cardiovascular risks: A population-based competing-risk analysisJeffrey S K Chan, Pias Tang, Jeremy M Ho Hui, et al.Cancer Research and Treatment|December 19, 2015
Mutation of Ha-ras Oncogene in Rat Salivary Gland Tumors Induced by DMBAB I Yeh, D P Han, J H Sohn, et al.Journal of Animal Physiology and Animal Nutrition|April 16, 2016
In vitro gas production of foliage from three browse tree species treated with different dose levels of exogenous fibrolytic enzymesD López, J F Vázquez-Armijo, N López-Villalobos, et al.Journal of Drug Targeting|May 10, 2007
Bio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicinJ J Yu, H A Lee, J H Kim, et al.The Journal of Cell Biology|May 2, 2007
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesisMark M Fuster, Lianchun Wang, Janice Castagnola, et al.Journal of Dairy Science|April 16, 2014
Preventive effect of fermented Maillard reaction products from milk proteins in cardiovascular healthN S Oh, H S Kwon, H A Lee, et al.Experimental Dermatology|September 28, 2006
Who is really in control of skin immunity under physiological circumstances - lymphocytes, dendritic cells or keratinocytes?J M Schröder, K Reich, K Kabashima, et al.Alimentary Pharmacology & Therapeutics|April 4, 2018
Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic areaH Y Kim, J Y Nam, J-H Lee, et al.Transplantation Proceedings|December 23, 2018
Risk Factors for Dropout From the Liver Transplant Waiting List of Hepatocellular Carcinoma Patients Under Locoregional TreatmentH A Lee, E Y Cho, T H Kim, et al.Pageof 9